Lee Jung-Tae, Lee Seok Hyun, Choi Baek Sun, Kim Sungtae
Department of Periodontics, One-Stop Specialty Center, Seoul National University Dental Hospital, Jongno-gu, Seoul, Republic of Korea.
Xenograft Development Team, Tissue Regeneration Institute, Osstem Implant Co. Ltd., Gangseo-gu, Seoul, Republic of Korea.
J Periodontol. 2025 Apr 2. doi: 10.1002/JPER.24-0663.
Collagenated bovine bone mineral (CBBM) is used for maxillary sinus elevation-based augmentation. We compared collagen degradation in cross-linked (CL) CBBM and non-cross-linked (NCL) CBBM (in vitro) and preclinical results in CBBM-CL, CBBM-NCL, deproteinized bovine bone mineral (DBBM), and DBBM with fibrin sealant grafts (in vivo) after repair of perforated Schneiderian membrane (SM).
Collagenase-based degradation rates of CBBM-CL and CBBM-NCL were compared in vitro and in vivo (CBBM-CL, CBBM-NCL, DBBM, and DBBM with fibrin glue; n = 12 defects per group). After bilateral maxillary SM perforation (5 mm) during sinus elevation, we performed bone substitute-based augmentation. At 4 and 12 weeks postoperatively, volumetric, histologic, and histomorphometric analyses were performed.
Complete degradation and 33% retention of collagen content after 24 and 72 h were noted in CBBM-NCL and CBBM-CL, respectively. CBBM-NCL demonstrated significant differences in total augmentation volume (TAV) compared to DBBM and DBBM with fibrin glue, as well as in new bone volume (NBV) compared to DBBM with fibrin glue. At 12 weeks, significant differences were observed between CBBM-NCL and DBBM in NBV. There were no significant differences across all groups in vertical bone increase in 4 and 12 weeks. DBBM and DBBM with fibrin glue showed more irregularly shaped patterns than CBBM-CL and CBBM-NCL. At 12 weeks, ossification progressed in all groups. At 4 weeks, DBBM with fibrin glue seemed to demonstrate early ossification at the perforation site in histological observations compared to DBBM alone; however, no differences were observed at 12 weeks.
CBBM for perforated SM repair confers bone stability and ossification. CBBM-CL was noninferior to CBBM-NCL in volume stability. The findings indicate that the CL collagen in CBBM-CL contributes to enhanced graft stability over time. Fibrin glue appeared to have a positive effect on early ossification in histological evaluations, but this effect was not evident at 12 weeks.
Collagenated bovine bone mineral (CBBM) is used for maxillary sinus elevation-based augmentation. We compared collagen degradation in cross-linked (CL) CBBM and non-cross-linked (NCL) CBBM (in vitro) and preclinical results in CBBM-CL, CBBM-NCL, deproteinized bovine bone mineral (DBBM), and DBBM with fibrin sealant (in vivo) after repair of perforated Schneiderian membrane (SM). After bilateral maxillary SM perforation (5 mm) during sinus elevation, we performed bone substitute-based augmentation. At 4 and 12 weeks postoperatively, volumetric, histologic, as well as histomorphometric analyses were performed. Based on this study, CL collagen in CBBM-CL contributes to enhanced graft stability over time. Fibrin glue appeared to have a positive effect on early ossification in histological evaluations, but this effect was not evident at 12 weeks.
胶原化牛骨矿物质(CBBM)用于基于上颌窦提升的骨增量手术。我们比较了交联(CL)CBBM和非交联(NCL)CBBM中胶原蛋白的降解情况(体外),以及在修复穿孔的施耐德膜(SM)后,CBBM-CL、CBBM-NCL、脱蛋白牛骨矿物质(DBBM)和使用纤维蛋白密封剂的DBBM移植物的临床前结果(体内)。
比较了CBBM-CL和CBBM-NCL基于胶原酶的体外和体内降解率(CBBM-CL、CBBM-NCL、DBBM以及使用纤维蛋白胶的DBBM;每组n = 12个缺损)。在鼻窦提升过程中双侧上颌SM穿孔(5毫米)后,我们进行了基于骨替代物的骨增量手术。术后4周和12周,进行了体积、组织学和组织形态计量学分析。
CBBM-NCL和CBBM-CL分别在24小时和72小时后出现胶原蛋白完全降解和33%的胶原蛋白含量保留。与DBBM和使用纤维蛋白胶的DBBM相比,CBBM-NCL在总骨增量体积(TAV)方面存在显著差异,与使用纤维蛋白胶的DBBM相比,在新骨体积(NBV)方面也存在显著差异。在12周时,CBBM-NCL和DBBM在NBV方面观察到显著差异。在4周和12周时,所有组在垂直骨增加方面没有显著差异。与CBBM-CL和CBBM-NCL相比,DBBM和使用纤维蛋白胶的DBBM呈现出更不规则的形态。在12周时,所有组的骨化均有进展。在4周时,组织学观察显示,与单独的DBBM相比,使用纤维蛋白胶的DBBM在穿孔部位似乎表现出早期骨化;然而,在12周时未观察到差异。
用于修复穿孔SM的CBBM可提供骨稳定性和骨化。CBBM-CL在体积稳定性方面不劣于CBBM-NCL。研究结果表明,CBBM-CL中的CL胶原蛋白随着时间的推移有助于增强移植物的稳定性。在组织学评估中,纤维蛋白胶似乎对早期骨化有积极作用,但在12周时这种作用不明显。
胶原化牛骨矿物质(CBBM)用于基于上颌窦提升的骨增量手术。我们比较了交联(CL)CBBM和非交联(NCL)CBBM中胶原蛋白的降解情况(体外),以及在修复穿孔的施耐德膜(SM)后,CBBM-CL、CBBM-NCL、脱蛋白牛骨矿物质(DBBM)和使用纤维蛋白密封剂的DBBM移植物的临床前结果(体内)。在鼻窦提升过程中双侧上颌SM穿孔(5毫米)后,我们进行了基于骨替代物的骨增量手术。术后4周和12周,进行了体积、组织学以及组织形态计量学分析。基于这项研究,CBBM-CL中的CL胶原蛋白随着时间的推移有助于增强移植物的稳定性。在组织学评估中,纤维蛋白胶似乎对早期骨化有积极作用,但在12周时这种作用不明显。